As FDA's Center for Drug Evaluation and Research continues to refine its Drug Trials Snapshots transparency program, it is inviting sponsors to propose their own edits to the publicly available summaries of demographic subgroup clinical trial data for recently approved products.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?